German vaccine developer CureVac said Wednesday its COVID-19 vaccine showed 48% efficacy against the virus, including the 15 known variants, in clinical trials.via Chebli Mohamed
German vaccine developer CureVac said Wednesday its COVID-19 vaccine showed 48% efficacy against the virus, including the 15 known variants, in clinical trials.
No comments:
Post a Comment
Nigeria News Comments are Moderated.
Clean Comments will be swiftly approved.
No swear words, no racism, allowed